Covered recipient · General Payments record
CELINA M NADELMAN
Allopathic & Osteopathic Physicians Pathology Cytopathology
General Payments · PY2018–2024
$461.38
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.05 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $75.76 | 3 |
| Daiichi Sankyo Inc. | $54.05 | 2 |
| Acerta Pharma LLC | $41.03 | 2 |
| Genentech USA, Inc. | $26.49 | 1 |
| ABBVIE INC. | $24.84 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.84 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105091773 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104692402 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.08 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104244695 | CMS |
| Daiichi Sankyo Inc. | $26.58 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461105 | CMS |
| Daiichi Sankyo Inc. | $27.47 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461107 | CMS |
| Genentech USA, Inc. | $26.49 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985445 | CMS |
| Merck Sharp & Dohme LLC | $24.41 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141815283 | CMS |
| Merck Sharp & Dohme LLC | $19.97 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141815281 | CMS |
| Merck Sharp & Dohme LLC | $31.38 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141815279 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $23.88 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139165002 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.